Ikonisys SA ALIKO
EURONEXT · France · Health Technology
€1.45+0.05 (+3.57%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
PARIS, September 21, 2026--Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces that its wholly-owned US subsidiary has reached a settlement resolving an existing dispute, pursuant to which it will receive a payment of USD 2 million.The related proceedings have been dismissed.
PARIS, September 15, 2026--Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces the launch of the Probantes project in Brazil, the ongoing incorporation of Probantes Ltda, a new Brazilian business unit wholly owned by Aliko Scientific Srl, and the signing of a strategic industrial cooperation agreement with Biodetecta – Life Science Ltda.
PARIS, September 07, 2026--Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces the successful launch of its collaboration with Partner International Inc., aimed at accelerating the Group’s development, notably in the United States, on the occasion of the ADLM 2026 exhibition in Anaheim, California.
PARIS, August 24, 2026--Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, today provides additional financial details following the publication, on July 30, 2026, of its 2025 annual results and its 2025 Annual Financial Report, while reaffirming its business momentum. This information pertains to the statutory auditors’ reports, the Company’s financial position and cash flow outlook s
PARIS, July 23, 2026--Regulatory News: Aliko Scientific SA (former Ikonisys SA - Euronext Growth Paris: ALIKO) – today announced that its wholly-owned Italian subsidiary, Hospitex International S.r.l., has signed a first agreement with the Jizzakh branch of the Republican Scientific and Practical Centre specialising in oncology and radiology in Djizak, Uzbekistan.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.